Common Contracts
4 similar Clinical Trial Research Agreement contracts
ContractClinical Trial Research Agreement • December 1st, 2017
CLINICAL TRIAL RESEARCH AGREEMENT(For Use in the Czech Republic with a CRO) This Agreement is entered into as of the last date on the signature page hereof, by and between Health Care Service Provider THOMAYEROVA NEMOCNICE, Vídeňská 800, 140 59 Praha 4, Czech Republic, ID 00064190, VAT ID: CZ00064190, StateContribution Organization set up by the Ministry of Health of the Czech Republic, Full Text of the Foulding File No. MZDR 17268-IV/2012, registered in the Commercial Register kept by the Municipal Court in Prague, section Pr, file 1043 bank details Česká národní banka, account number XXX, represented by doc. MUDr. Zdeněk Beneš, CSc., director(hereinafter called "Provider) andCOVANCE, INC. 206 Carnegie Center Princeton NJ, 08540 USA hereinafter called "CRO" whom MERCK SHARP & DOHME CORP. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889 USA, hereinafter called "Sponsor" has contractually engaged as a contract research organization concerning the management, fundi
ContractClinical Trial Research Agreement • November 27th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT(For Use in the Czech Republic with a CRO only in conjunction withPrincipal Investigator Contract for Work) This Agreement is entered into as of the last date on the signature page hereof, by and between Health Care Service Provider NEMOCNICE NA BULOVCE. Budínova 67/2, 180 81 Praha 8 – Libeň, Czech Republic, bank details Česká národní banka, account number XXX, represented by XXX(hereinafter called "Provider") and COVANCE, INC. 206 Carnegie Center Princeton NJ, 08540 USA hereinafter called "CRO" whom MERCK SHARP & DOHME CORP. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889 USA, hereinafter called "Sponsor" has contractually engaged as a contract research organization concerning the management, funding and administration of the Study (as defined below in Article 1) on behalf of the Sponsor. SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ(Pro použití v České republice s CRO pouze v kombinaci se Smlouvou o dílo pro hlavního zkoušejícího) T
ContractClinical Trial Research Agreement • July 28th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT (For Use in the Czech Republic with a CRO only in conjunction with Principal Investigator Contract for Work) This Agreement is entered into as of the last date on the signature page hereof, by and between Health Care Service Provider KRAJSKÁ ZDRAVOTNÍ, A.S., Sociální péče 3316/12A, 400 11 Ústí nad Labem, Czech Republic, bank details XXX, account number XXX, represented by Ing. Petr Fiala, Director General (hereinafter called "Provider") and COVANCE, INC. 210 Carnegie Center Princeton NJ, 08540 USA hereinafter called "CRO" whom MERCK SHARP & DOHME CORP. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889 USA, hereinafter called "Sponsor" has contractually engaged as a contract research organization concerning the management, funding and administration of the Study (as defined below in Article 1) on behalf of the Sponsor. and XXX, (hereinafter called “Principal Investigator”) SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ(Pro použití v Česk
ContractClinical Trial Research Agreement • July 28th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT (For Use in the Czech Republic with a CRO only in conjunction with Principal Investigator Contract for Work) This Agreement is entered into as of the last date on the signature page hereof, by and between Health Care Service Provider KRAJSKÁ ZDRAVOTNÍ, A.S., Sociální péče 3316/12A, 400 11 Ústí nad Labem, Czech Republic, bank details XXX, account number XXX, represented by Ing. Petr Fiala, Director General (hereinafter called "Provider") and COVANCE, INC. 210 Carnegie Center Princeton NJ, 08540 USA hereinafter called "CRO" whom MERCK SHARP & DOHME CORP. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889 USA, hereinafter called "Sponsor" has contractually engaged as a contract research organization concerning the management, funding and administration of the Study (as defined below in Article 1) on behalf of the Sponsor. and XXX, (hereinafter called “Principal Investigator”) SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ(Pro použití v Česk
